R84G (p.Arg84Gly) variant of KRT3 (Keratin, type II cytoskeletal 3)

R84G (p.Arg84Gly) in KRT3 (Keratin, type II cytoskeletal 3) is a missense change. Clinical records from EBI and UniProt describe it as benign. The available variant effect predictions contribute to a CATVariant prioritization score of 0.25 / 1. The record also includes population frequency data and structural context.

R84G (p.Arg84Gly) variant details